Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 15.6 | 31.0 | 9.2 | 24.9 |
| Revenue growth | -49.6% | 237.0% | -63.1% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 32.2 |
| Gross profit | 15.6 | 31.0 | 9.2 | -7.3 |
| Gross margin | 100.0% | 100.0% | 100.0% | -29.3% |
| Research and development | 64.3 | 47.1 | 44.8 | |
| General and administrative | 22.2 | 18.0 | 8.9 | 7.3 |
| EBIT | -70.9 | -34.1 | -44.5 | -18.5 |
| EBIT margin | -454.0% | -110.2% | -484.2% | -74.2% |
| Pre-tax income | -68.8 | -34.1 | -44.3 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | |
| Net income | -68.8 | -34.1 | -44.3 | 0.0 |
| Net margin | -440.3% | -110.1% | -481.4% | 0.0% |
| |
| Diluted EPS | ($1.90) | ($1.22) | ($16.00) | $0.00 |
| Shares outstanding (diluted) | 36.2 | 28.0 | 2.8 | 2,648.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|